Quarterly report [Sections 13 or 15(d)]

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)

v3.26.1
Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value $ 49,614 $ 59,511
Total liabilities at fair value 33,516 25,740
Level 1 | Money Market Funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market fund 8,774 23,111
Level 1 | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 0 990
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration asset related to sale of business 31,758 27,700
Indemnity holdback related to sale of business 9,082 8,700
Share-based payment liability-classified related to sale of business 16,851 15,138
Level 3 | Keystone Perfusion Services, LLC.    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Equity consideration in escrow and contingent consideration - Keystone acquisition 13,665 9,072
Level 3 | Louisville Perfusion Services    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Equity consideration in escrow and contingent consideration - Keystone acquisition 3,000 0
Level 2 | Private Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities $ 0 $ 540